RxDoctor Payments Data

April Christ

Family · Princeton, WVNPI 1043628654

Payments from drug & device makers

$1,182in general payments, 2019–2025

Across 58 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$292
  • AstraZeneca$197
  • Lantheus Medical Imaging, Inc.$105
  • Boehringer Ingelheim$92
  • Atricure, Inc.$90
  • Novo Nordisk$88
  • plus $319 from 6 others

What the payments were for

  • Food & beverage$1,15097%
  • Education$323%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,182 in reported general payments places this provider in the 70th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$36,411
Medicare patients
316
Services billed
398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$73,471
EntrestoSacubitril/Valsartan28$39,424
BrilintaTicagrelor28$23,124
JardianceEmpagliflozin22$22,357
FarxigaDapagliflozin Propanediol31$22,301
Repatha SureclickEvolocumab16$14,376
Metoprolol Succinate192$2,579
Ranolazine ErRanolazine29$1,742
Atorvastatin Calcium123$998
Telmisartan45$962
Diltiazem 24hr Er (Cd)Diltiazem Hcl24$879
Rosuvastatin Calcium66$813
ClopidogrelClopidogrel Bisulfate89$792
Ezetimibe27$745
Isosorbide Mononitrate ErIsosorbide Mononitrate76$739

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta, Farxiga$197$45,42559 claims
NovartisEntresto$73$39,42428 claims
Boehringer IngelheimJardiance$92$22,35722 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,507 family providers in West Virginia.

Other family in Princeton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →